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A collagen-binding strain of Staphylococcus aureus produced suppurative inflammation in a rabbit model of
soft contact lens-associated bacterial keratitis more often than its collagen-binding-negative isogenic mutant.
Reintroduction of the cna gene on a multicopy plasmid into the mutant helped it regain its corneal adherence
and infectivity. The topical application of a collagen-binding peptide before bacterial challenge decreased S.
aureus adherence to deepithelialized corneas. These data suggest that the collagen-binding adhesin is involved
in the pathogenesis of S. aureus infection of the cornea.
Our understanding of the pathogenesis of infectious diseases
of the eye is emerging. The intact ocular surface thwarts most
microorganisms, but predisposing factors such as contact lens
wear can expose tissue components conducive to bacterial ad-
hesion. A breakdown in local defenses and a source of micro-
bial contaminants increase the risk of eye infection.
Staphylococcus aureus is responsible for many types of hu-
man ocular infections (21) and accounts for 10% of culture-
positive microbial keratitis at our institution. S. aureus adheres
to the injured cornea (12) and releases proteins that disrupt
corneal tissue (11).
S. aureus possesses a family of adhesins that are localized at
the microbial surface and that interact with extracellular matrix
components such as collagen, fibronectin, fibrinogen, laminin,
and elastin with high affinity and specificity (4, 13). One staph-
ylococcal adhesin is composed of an N-terminal domain with a
collagen-binding site and an antipodal domain that attaches to
the bacterial cell wall and projects into the cytoplasm (16). We
sought to determine whether a rift in the corneal epithelial
surface would increase the risk of corneal adherence and in-
fection by collagen-binding S. aureus.
Previous animal models of staphylococcal keratitis used di-
rect intrastromal injection to infect the cornea (1, 2, 5, 7, 9).
However, direct inoculation into the corneal stroma does not
allow the investigation of bacterial adherence to the corneal
surface, a critical initial event in the pathogenesis of microbial
keratitis. Because staphylococci attach to contact lenses (3), an
animal model using soft contact lenses contaminated with S.
aureus was developed to study the role of bacterial adherence
in the initiation of keratitis. To enhance the risk of infection,
we applied a high-inoculum challenge to surface-injured cor-
neas. This model was then used to study the biological role of
the collagen-binding adhesin in S. aureus keratitis by compar-
ing the levels of virulence of a parental strain (Cna1), its
isogenic mutant (Cna2), and the isogenic mutant comple-
mented with an intact version of the gene (cna) encoding the
collagen-binding adhesin. We also studied the protective effect
of applying adhesin analogs before bacterial challenge.
Rabbit model of S. aureus keratitis. The animals used in this
study were treated according to the criteria of the Association
for Research in Vision and Ophthalmology Resolution on the
Use of Animals in Research. In the first set of experiments, a
masked comparison was made between the Cna1 strain and its
Cna2 isogenic mutant (15). New Zealand White rabbits (eight
in each group) were anesthetized by subcutaneous injection of
ketamine (35 mg/kg of body weight) and xylazine (5 mg/kg of
body weight). The corneal epithelium of the right eye of each
rabbit was marked with a 9-mm trephine and then debrided
within this area by using a Paton spatula. New etafilcon A
contact lenses (Acuvue; Vistakon, Jacksonville, Fla.) that had
been incubated at 35°C for 24 h in tryptic soy broth (TSB)
containing 108 CFU/ml were placed onto the deepithelialized
corneas. The nictitating membranes were removed to prevent
dislocation of the contact lens, and the eyelids were sutured
closed with 6-0 braided polyester. Eyelids were opened 48 h
after contact lens placement, and slit-lamp biomicroscopy of
the rabbit corneas was performed to determine the presence or
absence of an epithelial defect with stromal suppuration. To
confirm the presence of S. aureus, corneal scrapings were in-
oculated onto blood agar plates and incubated at 35°C. Cor-
neas were then removed, embedded in paraffin, sectioned at 6
mm, stained with hematoxylin-eosin, and examined by light
microscopy. In a second set of experiments, the virulence levels
of the Cna2 mutant and its complemented derivative were
compared by using the same rabbit model (five rabbits in each
group).
Contact lens contamination. To determine whether rabbit
corneas were exposed to similar amounts of bacteria, 10 new
soft contact lenses (Acuvue) were incubated in TSB containing
108 bacteria for 24 h at 35°C. The contaminated contact lenses
were washed with phosphate-buffered saline (PBS) to remove
planktonic bacteria and then placed in tubes containing 2 ml of
PBS and 10 glass beads that were vortexed for 2 min to dis-
lodge adherent bacteria. A 0.5-ml aliquot was removed from
the solution, and serial dilutions were plated on blood agar.
Colony counts were quantified after 48 h of incubation at 35°C.
An average of 2.4 3 106 CFU of the parental Cna1 strain
adhered to each contact lens, which was not significantly dif-
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ferent from the average of 3.6 3 106 CFU per lens for the
Cna2 mutant (P 5 0.61).
Construction of a cna-complemented S. aureus strain. To
restore collagen-binding activity to the S. aureus isogenic mu-
tant, the entire cna gene together with upstream DNA was
amplified by PCR from S. aureus FDA 574 chromosomal DNA
by using Taq polymerase (Life Technologies, Gaithersburg,
Md.) and oligonucleotides 59 GGTACCGGATCCACAGCTT
CCGGTTTAATAGGTGTA 39 (forward) and 59 CGAGGTA
CCAGAACTAAGAATAGCCTTATC 39 (reverse). BamHI
and KpnI restriction enzyme sites (underlined) were incorpo-
rated into the forward and reverse primers, respectively. The
4.2-kb PCR product was cloned into the Escherichia coli vector
pGEM-3 (Promega, Madison, Wis.) and used to transform E.
coli JM101 cells. A pGEM-3 derivative containing the cna gene
was digested with BamHI-EcoRI, releasing a 4.2-kb fragment
that was then ligated to BamHI-EcoRI-cleaved E. coli-S. au-
reus shuttle vector pL150 encoding chloramphenicol resistance
and transformed into JM101 cells. Plasmid DNA, isolated
from E. coli clones containing the proper plasmid construct,
was then used to electrotransform S. aureus RN4220. To select
for S. aureus RN4220 cells harboring the plasmid, cells were
plated on tryptic soy agar (TSA) containing 5 mg of chloram-
phenicol per ml. Chloramphenicol-resistant (Cmr) S. aureus
colonies were screened by restriction digest analysis, and one
transformant was selected (pCNA4.2). Finally, pCNA4.2 from
S. aureus RN4220 was used to electrotransform the gentami-
cin-resistant (Gmr) isogenic mutant. Transformants were
plated on TSA containing gentamicin at 10 mg/ml and chlor-
amphenicol at 5 mg/ml, yielding a Gmr Cmr transformant con-
taining pCNA4.2.
Collagen-binding activity of S. aureus strains. The parental
Cna1 strain, its Cna2 isogenic mutant, and the cna-comple-
mented strain (Cna1) were analyzed for their collagen-binding
activity. As shown in Fig. 1, S. aureus Cna1 and Cna2 strains
bound 75.3 and 3.7%, respectively, of the added 125I-labeled
bovine collagen type II. The cna-complemented strain bound
levels of 125I-labeled collagen similar to those of the wild-type
strain.
Comparison of S. aureus strains in the rabbit model of
keratitis. The corneas from six (75%) of the rabbits subjected
to soft contact lenses contaminated with the parental Cna1 S.
aureus strain developed bacterial keratitis, as evidenced by
dense, suppurative stromal infiltration. Cultures confirmed the
presence of S. aureus in all inflamed corneas. None of the
corneas exposed to the isogenic mutant developed suppurative
keratitis, even though in all cases the induced epithelial defect
was visible. The difference between the two groups was statis-
tically significant (P 5 0.007). Histopathological examination
of corneas exposed to the parental Cna1 S. aureus strain re-
vealed bacteria attached to the corneal surface and within the
corneal stroma, dense neutrophil infiltration, and a marked
disruption of tissue integrity (Fig. 2).
In the second phase of the study, corneas from four (67%) of
the rabbits exposed to contact lenses contaminated with the
cna-complemented strain developed central suppurative kera-
titis, whereas two (40%) of the rabbits exposed to the Cna2
mutant developed bacterial keratitis. Corneal scrapings dem-
onstrated the presence of S. aureus in all clinically infected
corneas.
Effect of topical adhesin on S. aureus corneal adherence. A
recombinant version of the collagen adhesin containing the
entire A-domain (M55; amino acid residues 30 to 529) was
produced by using the pOE vector (Qiagen, Chatsworth, Cal-
if.) as described previously (14). The purified protein was dis-
solved in PBS to yield a solution containing 200 mg/ml (8).
After debriding of the corneal epithelium, 9-mm-diameter cen-
tral corneal buttons were excised and either were processed
immediately or were first immersed in the adhesin solution for
15 min (two buttons in each group). Five microliters of TSB
containing 108 CFU/ml was applied to the surface of each
corneal button, which was then incubated at room temperature
for 60 min. Scanning electron microscopy showed that the
mean number of adherent bacteria in the nonpretreated con-
trol group was 7.5 3 104 per mm2 of corneal surface area, while
that of the pretreated corneas averaged 1.2 3 104 per mm2.
Bacterial adherence involves surface-associated microbial
proteins that bind to tissue ligands (6, 18). The collagen adhe-
sin of S. aureus is a virulence factor in experimental bacterial
arthritis and osteomyelitis (19). We now report that a contact
lens-associated ulcerative keratitis model can be used to inves-
tigate the dynamics of bacterial adherence to the injured cor-
neal surface. Significantly more eyes exposed to collagen-bind-
ing strains of S. aureus developed bacterial keratitis than eyes
exposed to an isogenic mutant lacking a functional collagen-
binding adhesin. Adhesin analogs decreased the amount of S.
aureus adhering to the deepithelialized cornea. These findings
implicate the role of adhesin-mediated bacterial adherence to
the cornea’s substrata in the pathogenesis of S. aureus keratitis.
Additional adhesion mechanisms may also be involved in
initiating staphylococcal corneal infection (10, 17), since only
one-third of our human S. aureus corneal isolates bind collagen
(data not shown). Our cna-deficient mutant caused bacterial
keratitis in a few animals, and preliminary experiments showed
similar rates of corneal infection for both an S. aureus strain
that does not bind collagen and its isogenic mutant into which
the cna gene was introduced. Also, topical ophthalmic ad-
hesins attenuated, but did not avert, bacterial keratitis follow-
ing S. aureus challenge (data not shown).
FIG. 1. Differential binding of 125I-labeled collagen type II by S. aureus
strains. The strains were incubated with 5 3 104 cpm of 125I-labeled collagen type
II for 1 h at room temperature. Bacterial binding was quantified as described
previously (20). Each sample was done in duplicate, and results are expressed as
the mean 6 standard deviation for the Cna1 parental strain (Phillips), the Cna2
isogenic mutant (PH100), and the cna-complemented mutant (PH101).
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This study demonstrates that the collagen-binding adhesin is
a virulence factor for S. aureus keratitis. A better understand-
ing of the early events that cause bacterial infection of the
cornea may lead to the development of therapeutics that can
inhibit bacterial binding and prevent microbial keratitis.
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